1. Is Pfizer’s established drugs’ decline in China a canary in a coalmine? — Amgen biosimilar debut boosted by UnitedHealthcare coverage — Novartis CEO says FDA process could’ve been handled better — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Any buyers yet

Discussion in 'Wolters Kluwer Health' started by Anonymous, Sep 13, 2011 at 5:50 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    They find anyone to buy Wolters Kluwer Health yet?
     
  2. Anonymous

    Anonymous Guest

    Ivanna Trump is in a bidding war with Kim Kardashian. Stay tuned.
     
  3. Anonymous

    Anonymous Guest

    Heard they were down to the final three contenders for a majority owner. Apparently, Wolters Kluwer wants to hang on to a minority part.

    Lord knows why... the leadership team are morons, especially when it comes to the sales/marketing part.
     
  4. Anonymous

    Anonymous Guest

    They sold the marketing and publishing services unit to Springer Science+Business Media. What about the analytics part?
     
  5. Anonymous

    Anonymous Guest

    Analytics part is supposed to close with a private equity group by the end of February.
     
  6. Anonymous

    Anonymous Guest

    Good for them! Just stay away from that f-ng mess known as the IMS-SDI acquisition.
     
  7. Anonymous

    Anonymous Guest

    Having worked deep in the inner circles of the "company" I can tell you that whomever invests, or, aquires better do their home work. I would question all numbers. Sr. Mgt. is the worst I have ever worked with.

    Many of their contracts are done through representing "false" data during RFPs which is how they sometimes win business. In the end they do not deliver what is represented in final contract if they are luck enough to win RFP.

    I have seen some funny things done that would not look to good in a court of law...both in personal management AND $ with clients.
     
  8. Anonymous

    Anonymous Guest

    STG acquires Source Healthcare Analytics, hope they do better than the last company did.
     
  9. Anonymous

    Anonymous Guest

    Unfortunately STG is going to dessimate Wolters Kluwer Pharma Solutions like they did to IRI many years back....already had a reduction in force of 40 people and will outsource all operations to their India facility....if I was still there I would be looking to get out fast!